Intellia Therapeutics

Intellia Therapeutics is a biotechnology company focused on developing gene editing treatments using technologies like CRISPR to target and modify specific genes within the body. Their goal is to create therapies that can cure genetic diseases, cancers, and other serious conditions by directly editing faulty genes. By doing so, they aim to offer more precise, effective, and potentially one-time treatments compared to traditional therapies. Intellia's work is at the forefront of personalized medicine, harnessing advanced molecular tools to address the root causes of various diseases.